1. Evidence-based medicine in pediatric rheumatology: Progress or peril

   • Thomas J. A. Lehman

   Invited Commentary Pages: 399 - 400

2. Defects in the disposal of dying cells lead to autoimmunity

   • Udo S. Gaipl
   • Sandra Franz
   • Martin Herrmann

   Invited Commentary Pages: 401 - 407

3. Web alert

   News Pages: 408 - 409

4. Literature alert

   Abstract Pages: 410 - 411

5. Clinical trials in kawasaki disease

   • Thomas J. A. Lehman

   Clinical Trials Report Pages: 415 - 416

6. Systemic manifestations in localized scleroderma

   • Francesco Zulian

   OriginalPaper Pages: 417 - 424

7. Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus

   • Laura E. Schanberg
   • Christy Sandborg

   OriginalPaper Pages: 425 - 433

8. The role of immune tolerance in preventing and treating arthritis

   • Gijs Teklenburg
   • Salvatore Albani

   OriginalPaper Pages: 434 - 441

9. Primary versus secondary antiphospholipid syndrome: Is this lupus or not?

   • Jennifer M. Grossman

   OriginalPaper Pages: 445 - 450

10. What is antiphospholipid syndrome?

    • Doruk Erkan
    • Michael D. Lockshin

    OriginalPaper Pages: 451 - 457

11. Genetics of antiphospholipid syndrome

    • Tetsuya Horita
    • Joan T. Merrill

    OriginalPaper Pages: 458 - 462

12. Treatment of the antiphospholipid antibody syndrome

    • Christopher Wu
    • Kenneth Kalunian

    OriginalPaper Pages: 463 - 468

13. Diagnosis of the antiphospholipid syndrome: How far to go?

    • Joan T. Merrill

    OriginalPaper Pages: 469 - 472